Avery Dennison Corporation (AVY):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Avery Dennison Corporation (AVY) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12180
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, RFID inlays and tags, and imprinting equipment and related services. It offers products under the brands such as Avery Dennison, Fasson, Monarch, JAC, Mactac and Vancive. Avery Dennison serves retailers, apparel manufacturers, and brand owners across Asia, Europe, North America, and Latin America. The company operates manufacturing facilities in the US, Belgium, Brazil, China, France, Germany, Luxembourg, Malaysia, the UK, Italy, and the Netherlands. Avery Dennison is headquartered in Glendale, California, the US.

Avery Dennison Corporation (AVY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avery Dennison Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avery Dennison Corporation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avery Dennison Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avery Dennison Corporation, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Avery Dennison Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avery Dennison Corporation, Medical Equipment, Deal Details 10
Partnerships 10
Avery Dennison And Preventice Partner To Develop Mobile Health Applications 10
Debt Offering 11
Avery Dennison Raises USD528.1 Million in Public Offering of Notes 11
Avery Dennison Completes Public Offering Of Notes Due 2023 For US$250 Million 13
Acquisition 15
Avery Dennison Acquires Finesse Medical 15
Avery Dennison Corporation – Key Competitors 16
Avery Dennison Corporation – Key Employees 17
Avery Dennison Corporation – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 22
Financial Announcements 22
Jul 24, 2018: Avery Dennison reports Q2 2018 results 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Avery Dennison Corporation, Medical Equipment, Key Facts, 2017 2
Avery Dennison Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Avery Dennison Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avery Dennison Corporation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avery Dennison Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avery Dennison Corporation, Deals By Market, 2012 to YTD 2018 8
Avery Dennison Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avery Dennison And Preventice Partner To Develop Mobile Health Applications 10
Avery Dennison Raises USD528.1 Million in Public Offering of Notes 11
Avery Dennison Completes Public Offering Of Notes Due 2023 For US$250 Million 13
Avery Dennison Acquires Finesse Medical 15
Avery Dennison Corporation, Key Competitors 16
Avery Dennison Corporation, Key Employees 17
Avery Dennison Corporation, Other Locations 19
Avery Dennison Corporation, Subsidiaries 19

List of Figures
Avery Dennison Corporation, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Avery Dennison Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Avery Dennison Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Avery Dennison Corporation, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Avery Dennison Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avery Dennison Corporation, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Avery Dennison Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avery Dennison Corporation, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Avery Dennison Corporation (AVY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hascol Petroleum Ltd (HASCOL):石油・ガス:M&Aディール及び事業提携情報
    Summary Hascol Petroleum Ltd (Hascol) is a petroleum product distributor. The company offers products such as rocket diesel, gasoline, fuel oil, tiger super and furnace oil, and FUCHS lubricants. Its FUCHS lubricants include corrosion preventives, quenching oils, industrial lube, industrial lube, sp …
  • Bank Hapoalim Bm
    Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Abbott Molecular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Molecular Inc (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical diagnostic company that provides molecular testing solutions. The company’s products include infectious disease products, oncology products, genetics products, automation products, molecular diagnostics …
  • Kemira Oyj (KEMIRA):企業の財務・戦略的SWOT分析
    Kemira Oyj (KEMIRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Covaris Inc-医療機器分野:企業M&A・提携分析
    Summary Covaris Inc (Covaris) is a technology company that offers pre-analytical tools and devices. The company’s products comprise instruments, kits and reagents and consumables. It offers kits and reagents which include truXTRAC FFPE DNA and RNA Kits; truXTRAC automation, FFPE sample collection, t …
  • Lannett Company Inc (LCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Lannett Company Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, c …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):電力:M&Aディール及び事業提携情報
    Summary Xinjiang GoldWind Science & Technology Co. Ltd. (Goldwind) is a wind energy company that manufactures wind turbine generator sets, develops wind farms and provides wind power services. The company researches, develops, manufactures and sells wind turbine generators and wind power components. …
  • China Southern Airlines Company Limited:戦略・SWOT・企業財務分析
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Anthem, Inc.:企業のM&A・事業提携・投資動向
    Anthem, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthem, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • WEC Energy Group Inc:発電所・企業SWOT分析
    WEC Energy Group Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Pfizer Ltd India (PFIZER):企業の財務・戦略的SWOT分析
    Summary Pfizer Ltd India (Pfizer India), a subsidiary of Pfizer Inc, is a pharmaceutical company that develops medicines for brain disorders. The company’s products portfolio comprises of anti-allergics, anti-diabetics, anti-histamines, anti-infectives, anti-parasitics, drugs for cardiovascular and …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • DS Smith Plc:企業のM&A・事業提携・投資動向
    DS Smith Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DS Smith Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Macquarie Infrastructure Corporation:企業のM&A・事業提携・投資動向
    Macquarie Infrastructure Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Infrastructure Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Chrysaor Holdings Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chrysaor Holdings Ltd (Chrysaor) is an oil and gas company that offers exploration services. The company develops, explores, produces and commercializes dormant oil and gas discoveries and incremental reserves in the North Sea. It acquires producing fields with associated undeveloped hydroca …
  • OncoMed Pharmaceuticals Inc (OMED):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • VSTECS Holdings Ltd:企業の戦略・SWOT・財務情報
    VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Crystal Rock Holdings, Inc:企業の戦略・SWOT・財務情報
    Crystal Rock Holdings, Inc - Strategy, SWOT and Corporate Finance Report Summary Crystal Rock Holdings, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Findel plc:企業の戦略・SWOT・財務情報
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆